Myriad Genetics Inc
(MYGN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 97,400 | 88,700 | 87,900 | 102,400 | 123,800 |
| Marketable Securities | 59,900 | 54,800 | 60,400 | 48,300 | 48,300 |
| Receivables | 127,000 | 127,100 | 120,100 | 111,300 | 119,200 |
| Inventories | 33,400 | 38,200 | 38,900 | 42,200 | 47,400 |
| TOTAL | $331,500 | $327,000 | $325,600 | $317,100 | $348,300 |
| Non-Current Assets | |||||
| PPE Net | 48,200 | 48,400 | 49,800 | 51,100 | 53,000 |
| Investments And Advances | 51,300 | 58,500 | 50,100 | 48,500 | 53,400 |
| Intangibles | 787,500 | 794,600 | 802,800 | 807,700 | 813,100 |
| TOTAL | $887,000 | $901,500 | $902,700 | $907,300 | $919,500 |
| Total Assets | $1,218,500 | $1,228,500 | $1,228,300 | $1,224,400 | $1,267,800 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 20,200 | 25,100 | 22,500 | 22,000 | 26,800 |
| Accrued Expenses | 64,100 | 60,800 | 59,800 | 65,600 | 64,000 |
| Other current liabilities | 7,400 | 70,000 | 54,000 | 127,300 | 128,200 |
| TOTAL | $94,300 | $159,300 | $139,200 | $217,500 | $221,700 |
| Non-Current Liabilities | |||||
| Long Term Debt | 69,300 | 43,200 | 74,200 | 99,100 | 167,100 |
| Deferred Revenues | 2,600 | 3,400 | 2,900 | 2,600 | 2,700 |
| Other Non-Current Liabilities | 44,400 | 51,000 | 53,200 | 45,600 | 46,400 |
| TOTAL | $175,800 | $155,000 | $218,500 | $229,100 | $298,200 |
| Total Liabilities | $270,100 | $314,300 | $357,700 | $446,600 | $519,900 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 69,907 | 69,850 | 69,241 | N/A | 68,118 |
| Common Shares | 700 | 700 | 700 | 700 | 700 |
| Retained earnings | 56,200 | 44,800 | 12,800 | -68,400 | -81,400 |
| Other shareholders' equity | 1,900 | -2,400 | -2,500 | -5,900 | -10,900 |
| TOTAL | $948,400 | $914,200 | $870,600 | $777,800 | $747,900 |
| Total Liabilities And Equity | $1,218,500 | $1,228,500 | $1,228,300 | $1,224,400 | $1,267,800 |